NEW YORK, July 20 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Javelin Pharmaceuticals, Inc. under the ticker symbol JAV. Javelin is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target the moderate-to-severe pain medication market segment. "The American Stock Exchange gladly welcomes Javelin Pharmaceuticals, Inc. to our market," said John McGonegal, Senior Vice President of Amex's Equities Group. "Javelin Pharmaceuticals performs important work in its industry, and we hope to be supportive of Javelin's endeavors as it seeks to expand and deliver its services to a demanding marketplace." "We are very pleased to be listed on the American Stock Exchange," stated Steve Tulipano, Javelin's Chief Financial Officer. "We at Javelin are confident that Amex listing will provide our shareholders and potential investors a greater degree of liquidity as Javelin proceeds to commercialize its three late stage drug candidates for the treatment of pain." The specialist in Javelin Pharmaceuticals, Inc. will be Weiskopf Silver & Co. For further information on JAV and other Amex-listed companies, please visit http://www.amex.com/. The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 188 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/. DATASOURCE: The American Stock Exchange CONTACT: Catherine Chantharaj of the American Stock Exchange, +1-212-306-1689 , Web site: http://www.amex.com/

Copyright